Differences in imeglimin response in subgroups of patients with type 2 diabetes stratified by data-driven cluster analysis: A post-hoc analysis of imeglimin clinical trial data.

Katsuhiko HagiKenji KochiHirotaka Watada Kohei KakuKohjiro Ueki

Published in: Diabetes, obesity & metabolism (2024)

Differences in imeglimin response were observed among T2D patient clusters. Patient stratification may help with selection of those most probable to respond to imeglimin.

Keyphrases

clinical trial
case report
electronic health record
study protocol
big data
randomized controlled trial
machine learning
phase ii
phase iii